Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies.

Epilepsia Open · 2018 · PMC6293070 · PMID 30564777

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

almost reached statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

There was a statistically significant difference in everolimus effects between the TSC and the non‐mTOR group (p = 0.049, chi‐square test, n = 9 and 7 cells, respectively), whereas the difference between mTOR (TSC and CD combined) and non‐mTOR pathologies almost reached statistical significance (p = 0.08, chi‐square test).

also in 378 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.